Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/16/16 → 01/22/20 |
Funding
- HedgePath Pharmaceuticals Incorporated: $95,000.22
SCORING Trial: Phase II(b) Open-Label Trial of SUBA-Itraconazole in Subjects with Basal Cell Carcinoma Nevus Syndrome (BCCNS)
- Jones, Evan C (PI)
- Kaufmann, Tara L. (CoPI)
- Slutsky, Jordan B. (CoPI)
- Korzenko, Adam (CoPI)
Project: Research